• Users Online: 95
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 23  |  Issue : 2  |  Page : 115-120

Prognostic value of hepatocyte growth factor in dialysis patients with heart failure

1 Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt
2 Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt
3 Department of Clinical Physiology, Faculty of Medicine, Fayoum University, Faiyum, Egypt

Correspondence Address:
Mervat M Naguib
Department of Internal Medicine, Cairo University, 11451
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/kamj.kamj_52_16

Rights and Permissions

Objective The aim of this study was to evaluate hepatocyte growth factor (HGF) as a predictor of short-term mortality in patients with chronic renal failure (CRF) and congestive heart failure (CHF) and study its relation to heart failure severity. Design The work was designed as a prospective case–control study. Patients and methods The study included 52 CRF patients with heart failure: 41 patients were on regular dialysis (group 1) and 11 patients were on conservative treatment (group 2). They were compared with 11 CHF patients with normal renal function (group 3), 10 CRF patients on regular dialysis and normal cardiac function (group 4), and 15 healthy controls (group 5). Initial baseline characteristics, New York Heart Association Classification of Heart Failure, serum HGF, and cardiac functions by echocardiography were determined. All groups were prospectively followed up for 6 months in order to determine mortality. Results The mean HGF level in group 1 (1.3±0.96 ng/ml), group 2 (0.65±0.25 ng/ml), group 3 (1.34±0.61 ng/ml), and group 4 (1.67±0.89 ng/ml) was significantly higher than the level in the control group (0.25±0.24 ng/ml) (P<0.0001). Post-hoc test showed a nonsignificant difference in HGF concentration between group 1 and other groups. Patients with a moderate degree of CHF in group 1 had significantly higher HGF than those with a mild degree (1.7±1 vs. 0.78±0.6 ng/ml) (P=0.002). In group 1, bivariate correlation analysis showed a positive correlation of HGF and left atrium diameter (r=0.34, P=0.03) and a negative correlation with ejection fraction (r=−0.45, P=0.0003). No statistically significant difference was found in HGF levels between patients who survived (1.27±0.94 ng/ml) and those who did not survive (1.26±0.75 ng/ml) in group 1 (P=0.9). Conclusion In this study, serum HGF was found to be a good marker of severity of heart failure in CRF patients undergoing dialysis. However, it was not associated with mortality.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded33    
    Comments [Add]    

Recommend this journal